⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24499318 | 0.86 | — | — | |
| SCHEMBL24499327 | 0.86 | — | — | |
| SCHEMBL24499286 | 0.86 | — | — | |
| SCHEMBL19152901 | 0.78 | CHRNA7 (0.36) | — | |
| SCHEMBL24499874 | 0.77 | — | — | |
| SCHEMBL18237546 | 0.74 | — | — | |
| SCHEMBL11977458 | 0.73 | NOS3 (0.45) | — | |
| SCHEMBL10220861 | 0.73 | NOS3 (0.50) | — | |
| SCHEMBL24499285 | 0.73 | — | — | |
| SCHEMBL24499311 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11213525-B2 | Linear glycosidase inhibitors | ASCENEURON SA (CH) | 2022-01-04 | — | — | US | disclosed |
| US-10995090-B2 | Substituted dihydrobenzofuran glycosidase inhibitors | ASCENEURON SA (CH) | 2021-05-04 | — | — | US | disclosed |
| US-20210077488-A1 | LINEAR GLYCOSIDASE INHIBITORS | ASCENEURON SA (CH) | 2021-03-18 | — | — | US | disclosed |